Database: NCZI Cancer Registry (Slovakia)

From Beacon
Revision as of 17:50, 13 November 2023 by Francine (talk | contribs) (Created page with "{{#subobject:NCZI Cancer Registry |dct:title=NCZI Cancer Registry |datatype=registry }} '''Sponsor, manager or home institution:''' Národné centrum zdravotníckych informácií. '''Primary purpose:''' to provide comprehensive and accurate information on the occurrence of oncological diseases in a defined population, enabling the evaluation and control of the impact of oncology in the community and informing public health priorities and cancer control activities. '...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


Sponsor, manager or home institution: Národné centrum zdravotníckych informácií.

Primary purpose: to provide comprehensive and accurate information on the occurrence of oncological diseases in a defined population, enabling the evaluation and control of the impact of oncology in the community and informing public health priorities and cancer control activities.

Type of information: No data dictionary was found for this database.

Available type of information: Estimated incidence of malignant tumors and incidence indicators according to diagnosis; Gender; Year; Age group; Territory and stage [1].

Source of Information: Data reported by relevant intelligence units (SJ) and healthcare providers (PZS) who are obligated to report patients with malignant tumors.

Data level: Patient level.

Available data level: Regional level.

Number of Records: Unknown.

Date Range: 1997 to 2012.

Cancer Areas of Interest: Malignant tumors and carcinomas in situ (C00-C96, D00-D09); Lips, oral cavity and pharynx (C00 – C14); digestive organs (C15 – C26); Respiratory and intrathoracic organs (C30 – C39); Bones and articular cartilage (C40 – C41); Melanoma and other skin cancers (C43 – C44); Mesothelium and soft tissue (C45 – C49); Breast (C50); Female genital organs (C51 – C58); Male genitalia (C60 – C63); Urinary system (C64 – C68); Eye, brain and other parts of the CNS (C69 – C72); Thyroid and other endocrine glands (C73-C75); Imprecisely determined, secondary and non-specific locations (C76 – C80); Lymphatic, hematopoietic and related tissue (C81 – C96); Carcinomas in situ (D00 – D09).

Data access: Partially publicly available [2]. Instructions to request data for restricted content [3].

Contact information: Information [4].